Thomas Gruber - Concepedia

Author

Thomas Gruber

Innsbruck Medical University ORCID

Also Known As

T GRUBER, Thomas Gruber

Publications

Citations

H-Index

Concepts

All Affiliations

Innsbruck Medical University Universität Innsbruck Austrian Academy of Sciences Institute of Molecular Biotechnology Tyrolean Cancer Research Institute

About

Thomas Gruber is an author at Innsbruck Medical University specializing in cell biology, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	758
2	Cell Biology	8	8	758
3	Immunology	6	6	720
4	Cellular Physiology	2	2	70
5	Autoimmune Disease	1	1	92

Thomas Gruber

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells Magdalena Paolino, Axel Choidas, Stephanie Wallner, Nature Cell SignalingMedicineImmunologyTam ReceptorsImmune Checkpoint Inhibitor	2014	449
Protein Kinase C θ Affects Ca2+ Mobilization and NFAT Activation in Primary Mouse T Cells Christa Pfeifhofer‐Obermair, Kurt Kofler, Thomas Gruber, The Journal of Experimental Medicine	2003	322
The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation Jean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke, Journal of Pharmacology and Experimental Therapeutics	2009	159
The Nuclear Orphan Receptor NR2F6 Suppresses Lymphocyte Activation and T Helper 17-Dependent Autoimmunity Natascha Hermann‐Kleiter, Thomas Gruber, Christina Lutz‐Nicoladoni, Immunity InflammationAutoimmune DiseaseImmune Cell DevelopmentT-regulatory CellImmunology	2008	92
Essential Role of E3 Ubiquitin Ligase Activity in <i>Cbl-b–</i>Regulated T Cell Functions Magdalena Paolino, Christine B.F. Thien, Thomas Gruber, The Journal of Immunology Molecular RegulationT-regulatory CellImmunologyImmune RegulationImmunotherapy	2011	91
Defective IgG2a/2b Class Switching in PKCα−/− Mice Christa Pfeifhofer‐Obermair, Thomas Gruber, Thomas Letschka, The Journal of Immunology	2006	88
PKC-θ Modulates the Strength of T Cell Responses by Targeting Cbl-b for Ubiquitination and Degradation Thomas Gruber, Natascha Hermann‐Kleiter, Reinhard Hinterleitner, Science Signaling	2009	77
A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma Stefan Salcher, Gilles A. Spoden, Judith Hagenbuchner, Oncogene	2019	71
The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance Natascha Hermann‐Kleiter, Victoria Klepsch, Stephanie Wallner, Cell Reports	2015	70
Adoptive Transfer of siRNA Cblb-Silenced CD8+ T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model Reinhard Hinterleitner, Thomas Gruber, Christa Pfeifhofer‐Obermair, PLoS ONE	2012	59

Page 1